ArticleJAMA network open2026
Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer.
Chuan Angel Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJAMA network open2026
Chuan Angel Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.